Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Phytopharm assumes increased responsibility for development of unique botanical product

April 7, 1999

Roche, deCode Genetics close in on osteoarthritis disease-causing gene

April 7, 1999

FDA approves ANDA for Oruvail

April 7, 1999

Prosorba Column now available in U.S. for treatment of rheumatoid arthritis

April 6, 1999

Bioniche enters supply agreement with Sanova for Suplasyn

April 6, 1999

Anika to initiate Orthovisc phase III clinical study in U.S. and Canada

April 5, 1999

New oral SLE therapy GL-701 awarded fast track designation

April 5, 1999

Cypress Bioscience closes partnership agreement with Fresenius

April 5, 1999

Celecoxib is an effective antipyretic agent in man

March 26, 1999

Celgene synthesizes potent TNF-alpha and PDE4 inhibitors

March 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...